Navigation Links
Elevated Insulin Levels To Influence Levels Of Inflammatory Markers

Increase in the levels of insulin can raise the level of inflammatory makers that influence the Alzheimer’s’ Disease. The study is being published by Archives of Neurology.

Conditions of insulin resistance and hyper-insulinemia are associated with elevated levels //of inflammatory markers and increase the risk for Alzheimer disease (AD). Inflammation has been proposed as a key pathogenic factor for AD.

Researchers from the University of Washington, Seattle, raised blood insulin levels (while maintaining normal blood sugar levels) in 16 healthy older adults ranging in age from 55 to 81 years, and then measured the changes in levels of inflammatory markers, modulators, and beta-amyloid (a protein associated with AD) in plasma and cerebrospinal fluid.

Moderate peripheral hyperinsulinemia (increased levels of insulin) provoked striking increases in CNS (central nervous system) inflammatory markers, the authors reported. Their findings suggest that insulin-resistant conditions such as diabetes mellitus and hypertension may increase the risk for AD, in part through insulin-induced inflammation.

Although this model has obvious relevance for diabetes mellitus, hyperinsulinemia and insulin resistance are widespread conditions that affect many nondiabetic adults with obesity, impaired glucose tolerance, cardiovascular disease, and hypertension. The results provide a cautionary note for the current epidemic of such conditions, which, in the context of an aging population, may provoke a dramatic increase in the prevalence of AD. More encouragingly, greater understanding of insulin’s role in AD pathogenesis may lead to novel and more effective strategies for treating, delaying, or even preventing this challenging disease, the authors had concluded.

Source: Newswise
'"/>




Page: 1

Related medicine news :

1. Elevated Ozone Levels Hurt Sperm Count
2. Elevated homocysteine levels linked to congestive heart failure risk
3. Elevated LDL levels in Childhood could be Predictors of Heart Disease
4. Elevated Blood Sugar Levels A Risk Factor Of Heart Disease
5. Diabetic Type II Women Have Elevated Bone Density Mass
6. Males Lifespan Shortened By Elevated Levels Of Testosterone
7. Adults Needs to be Educated About the Dangers of Elevated TVs
8. Discovery of Elevated Amyloid Peptide levels could lead to Alzheimer’s Preventio
9. New Therapy to Treat Patients With Severely Elevated Cholesterol Levels
10. Study Attributes Elevated Liver Enzymes in HIV/hepatitis to Coinfection Rather Than Antiretrovirals
11. Higher Trans Fat Levels in Blood Associated With Elevated Risk of Heart Disease
Post Your Comments:
(Date:8/7/2008)...egree to which people are able to adopt realistic ...hope, have been overlooked in policies to tackle H...Social Research Council (ESRC) argues that hope is...of HIV/AIDS. , Almost 30 years into the AIDS epid...sive. Efforts to control the spread of HIV have be...
(Date:8/7/2008)...tive study appearing in the August issue of The J... time, if noseless bicycle saddles would be an eff...alth effects, erectile dysfunction and groin numbn... with a protruding nose extension. Results from th... recreational cyclists to alleviate perineal disco...
(Date:8/7/2008)...ID millions who don,t know they have disease , ...idely used test to monitor blood sugar levels in p...f people with undetected diabetes, according to a ... , The hemoglobin A1c test (HbA1c) shows how m...n the previous 120 days, the average life span of ...
(Date:8/7/2008)... -- GlaxoSmithKline (NYSE:,GSK) today announced th...-daily EPZICOM (abacavir + lamivudine) provides co...vir DF + emtricitabine) as a first-line option,for...ay at the 17th,International AIDS Conference in Me...pective, long-term, head-to-head trial to,evaluate...
Breaking Medicine News(10 mins):Health News:Hope: An overlooked tool in the battle against HIV/AIDS 2Health News:No-nose bicycle saddles improve penile sensation and erectile function in bicycling police officers 2Health News:Blood Sugar Test May Also Aid Diabetes Detection 2Health News:Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients 2Health News:Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients 3Health News:Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients 4Health News:Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients 5
...me of lifting, bending and normal wear and tear.//...o relieve stress while going about your daily acti...r in arthritis care. If you’ve lived long enough, ... shoulder, elbow and wrist can cause pain, swellin...
... A protein called Human beta defensin 4 (HBD4) is ... present through out the body and helps it to figh...t this could be produced by genetically modified s...f researchers led by Dorothy Supp, a researcher an...
... Prevention has reported that many have come down ...requiring// hospital admission. The number of pat...utbreak. Explaining the extent of impact, CDC sa...isted in 67 hospitals spanning 18 districts and co...
...dreaded flu or influenza is just a step away; from...03 released// the FluMist, a popular influenza vir...t which has been approved by the Food and Drug A...same name FluMist, or by its clinical name CAIV-T ...
Other Medicine News:Health News:Nine Ways to Relieve Joint Stress 2
(Date:8/8/2008)...urkhalter, BOSTON, Aug. 8 /- Francis...dant fruit beverage every day could help protect,h...out after participating,in a clinical trial near h...cted by Bell Ventures, shows that after just 7 day...iovascular disease (CVD),was significantly reduce...
(Date:8/8/2008)...Innocoll, Inc., a privately-held,biopharmaceutical... dosed,in the first of three ongoing phase 2 clini...y, Innocoll Technologies Ltd, to investigate,Colla...ent of,post-operative pain., Innocoll,s BUPIVACAI...ioresorbable matrix of purified fibrillar collagen...
(Date:8/7/2008)...-- ProteoTech Inc. (ProteoTech),today announced th... Drug,(IND) requirements and has been cleared by t...l on Exebryl-1(R), a novel small molecule drug tar... the treatment of Alzheimer,s,disease. ProteoTech ...., At the 2008 International Conference on Alzhei...
(Date:8/7/2008)...ical Trial of ALXN6000 in Cancer, CHESHIRE, Conn....euticals, Inc. (Nasdaq: ALXN ) today announced th... Patent Number 7,408,041 titled,"Polypeptides and...mia,Cells and Uses Thereof." The patent is assigne...e composition-of-matter of Alexion,s anti-CD200,hu...
Breaking Medicine Technology:ViaViente Demonstrates Cardiovascular Benefits in New Human Trial 2ViaViente Demonstrates Cardiovascular Benefits in New Human Trial 3Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 2Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 3Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 4ProteoTech's Exebryl-1(R) Enters Human Clinical Trials for the Treatment of Alzheimer's Disease 2Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody 2Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody 3Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody 4LifeNet Health and IMS Announce Partnership 1979 1LifeNet Health and IMS Announce Partnership 1979 2Clinical Data Presented on OrthoGlide 28R 29 Medial Knee Implant 932 1Clinical Data Presented on OrthoGlide 28R 29 Medial Knee Implant 932 2Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF 1019 929 1Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF 1019 929 2Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF 1019 929 3National Heart Lung and Blood Institute creates national network to study cardiovascular disease 7110 1National Heart Lung and Blood Institute creates national network to study cardiovascular disease 7110 2
Cold light source triple outlet.
Cold light source dual outlet.
Cold light source dual outlet.
The 4150S is a state of the art 150 Watt halogen light source with an integrated intensity control and a standard coupler to connect optical fiber light guides. This light source distinguishes itself
Medicine Products: